ACA
FCSC

Apis Capital Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Apis Capital Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,000
Closed -$48K – 41
2019
Q1 		$48K Buy
+25,000
New +$49.8K 0.06% 31

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Apis Capital Advisors's FCSC Position: Q2 2019 in Review

Apis Capital Advisors sold out of Fibrocell Science Inc. (FCSC) in Q2 2019, closing a stake of 25,000 shares — an estimated $48K sold.

Apis Capital Advisors first reported a position in FCSC in Q1 2019 and held it in 1 quarter. The position peaked at $48K in Q1 2019. 20 funds tracked by Wall St. Rank hold FCSC as of Q2 2019.

  • Apis Capital Advisors reported no remaining Fibrocell Science Inc. position as of Q2 2019 after selling out during the quarter.
  • Apis Capital Advisors sold 25,000 Fibrocell Science Inc. shares in Q2 2019, an estimated $48K.
  • Apis Capital Advisors first reported a position in Fibrocell Science Inc. in Q1 2019 and held it in 1 quarter.
  • Apis Capital Advisors's Fibrocell Science Inc. position peaked at $48K in Q1 2019.
  • 20 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2019.

Based on Apis Capital Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.